Share
PrintThe Cancer Genome Atlas 2nd Annual Scientific Symposium:
Enabling Cancer Research Through TCGA
On November 27-28, 2012, The Cancer Genome Atlas (TCGA) held its second annual scientific symposium at The Crystal Gateway Marriott in Crystal City, Va. Through collaborative workshops, poster sessions and plenary presentations, TCGA investigators from around the world shared their novel biological discoveries, analytical methods and translational approaches using TCGA data.
Available in the table below are videos and accompanying slides from the symposium.
Also available as a video playlist on GenomeTV
View symposium videos and slides from:
Tuesday, November 27, 2012
| 1 | TCGA Status Report and Insights From Leadership
|
Kenna Shaw, Ph.D. The Cancer Genome Atlas Program |
| 2 | TCGA Status Report and Insights From Leadership
|
Stephen Chanock, M.D. National Cancer Institute |
| 3 | TCGA Status Report and Insights From Leadership
|
Louis M. Staudt, M.D., Ph.D. National Cancer Institute |
| 4 |
TCGA Status Reports and Insight from Leadership Q&A
|
Matthew Meyerson, M.D. Dana-Farber Cancer Institute Ilya Shmulevich, Ph.D. Institute for Systems Biology |
| 5 | TCGA Clear Cell Renal Cell Carcinoma Project
|
Chad J. Creighton, Ph.D. Baylor College of Medicine |
| 6 | Analysis of Somatic Mutations Across Many Tumor Types
|
Petar Stojanov Dana-Farber Cancer Institute/Broad Institute |
| 7 | CRAVAT and muPIT: Web Services for High-Throughput Analysis of Sequence Variation in Cancer
|
Rachel Karchin, Ph.D., M.S. Johns Hopkins University |
| 8 | High-Grade Serous Ovarian Adenocarcinoma Transcriptome Sequencing
|
Andrew J. Mungall, Ph.D. British Columbia Cancer Agency |
| 9 | Adverse Outcomes in Clear Cell Renal Cell Carcinoma With Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2
|
Ari Hakimi, M.D. Memorial Sloan-Kettering Cancer Center |
| 10 | Individual Patient Cancer Profiles in The Cancer Genome Atlas
|
Jianjiong Gao, Ph.D. Memorial Sloan-Kettering Cancer Center |
| 11 | Comprehensive Genomic Characterization of Squamous Cell Carcinoma of the Head and Neck
|
David Neil Hayes, M.D. The University of North Carolina at Chapel Hill |
| 12 | Genomic Characterization of Cancer-Adjacent Tissue: Evidence of Field Effects and Expression Subtypes
|
Melissa Troester, Ph.D., M.P.H. The University of North Carolina at Chapel Hill |
| 13 | Genome-Wide Analysis of Expression Quantitative Trait Loci in Breast Cancer
|
Nicholas W. Knoblauch Harvard Medical School |
| 14 | Pathway and Network Analysis of Somatic Mutations Across Cancer Types in TCGA
|
Ben Raphael, Ph.D. Brown University |
| 15 | Detection, Diagnosis and Correction of Batch Effects in TCGA Data
|
Rehan Akbani, Ph.D. The University of Texas MD Anderson Cancer Center |
| 16 | Papillary Thyroid Carcinoma Analysis
|
Thomas Giordano, M.D., Ph.D. University of Michigan Medical School |
Wednesday, November 28, 2012
| 17 | The Bladder Cancer Analysis Working Group (BLCA AWG): A Progress Report
|
John N. Weinstein, M.D., Ph.D. The University of Texas MD Anderson Cancer Center |
| 18 | Identification of Gene Fusions Using RNA Sequencing Data
|
Siyuan Zheng, Ph.D. The University of Texas MD Anderson Cancer Center |
| 19 | Comparative Mutational Analysis in Frozen and FFPE Tumor Samples
|
Gaddy Getz Ph.D. The University of Texas MD Anderson Cancer Center / Broad Institute |
| 20 | Structural Variant Detection in Colorectal Cancer
|
Evert van den Broek, M.D., Ph.D. VU University Medical Center Amsterdam |
| 21 | FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma Are Sensitive to Inhibition by Targeted Therapies
|
Rachel G. Liao Harvard University |
| 22 | Analysis of 3,000 Cancer Exomes to Identify Novel Cancer Drivers and Therapeutic Opportunities
|
Nickolay Khazanov, Ph.D. Compendia Bioscience |
| 23 | Integrated Genomic Characterization of Endometrial Carcinoma
|
Douglas A. Levine, M.D. Memorial Sloan-Kettering Cancer Center |
| 24 | Assessing Tumor Heterogeneity and Tracking Clonal Evolution Using Whole Genome or Exome Sequencing
|
Christopher A. Miller, Ph.D. The Genome Institute at Washington University |
| 25 | TCGA Benchmark 4: Evaluating SV and SNV Calls Using Cell Line Genomes
|
Adam Ewing, Ph.D. University of California, Santa Cruz |
| 26 | The Molecular Diversity of Luminal A Breast Tumors
|
Giovanni Ciriello, Ph.D. Memorial Sloan-Kettering Cancer Center |
| 27 | The Somatic Genomic Landscape of Glioblastoma Multiforme
|
Roel Verhaak, Ph.D. The University of Texas MD Anderson Cancer Center |
| 28 | Network-Based Stratification of Tumor Mutations
|
Matan Hofree, M.S. University of California, San Diego |
| 29 | Comprehensive Analysis of Lung Adenocarcinoma
|
Matthew Meyerson, M.D. Dana-Farber Cancer Institute |
| 30 | Predicting Time to Ovarian Carcinoma Recurrence Using Protein Markers
|
Ji-Yeon Yang, Ph.D. The University of Texas MD Anderson Cancer Center |
| 31 | Polymerase Epsilon Mutations Accelerate Mutation Rates in Colorectal and Endometrial Cancer
|
David A. Wheeler, Ph.D. Baylor College of Medicine |
| 32 | Virus Analysis in Head and Neck and Bladder Cancers
|
Michael Parfenov, M.D., Ph.D., M.S. Harvard Medical School |
| 33 | GeneSpot: A Portal for Interactive Gene-Centric Exploration of The Cancer Genome Atlas
|
Brady Bernard, Ph.D. and Hector Rovira Institute for Systems Biology |
| 34 | Functional Characterization of KEAP1 TCGA Mutants in Squamous Cell Carcinoma
|
Bridgid E. Hast The University of North Carolina at Chapel Hill |
| 35 | Remarks About the Success of the TCGA Program
|
Harold Varmus, M.D. National Cancer Institute |
| 36 | Keynote Talk
|
William Sellers, M.D. Novartis Institutes for BioMedical Research, Inc. |
| 37 | Closing Remarks
|
Matthew Meyerson, M.D. Dana-Farber Cancer Institute |
| 38 | TCGA 2012 Poster Session
|
|
To view the PDF document(s) on this page, you will need Adobe Reader. 
Last Updated: January 9, 2013
Leave a Comment!
We encourage you to share your thoughts as they relate to the topics being discussed on genome.gov, other websites or discussion forums owned or administered by the National Human Genome Research Institute (NHGRI). We review all comments for posting. We do not discriminate against any views, but we reserve the right not to post comments, or to remove comments, that are inconsistent with our Comment Policy, at our complete discretion.
Excellent materials for researchers. Professor Amit Chakravarty, Kolkata, India